Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela A Moise

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Clinical Microbiology|June 9, 2004
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaGeorge Sakoulas, Pamela A Moise-Broder, Jerome Schentag, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2009
Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studiesPamela A Moise, Davida S Smyth, D Ashley Robinson, et al.
The Journal of Infectious Diseases|December 17, 2009
Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypesPamela A Moise, Alan Forrest, Arnold S Bayer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapyPamela A Moise-Broder, George Sakoulas, George M Eliopoulos, et al.
Mycoses|February 6, 2023
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospitalsKarri A Bauer, Kalvin Yu, Pamela A Moise, et al.
Current Medical Research and Opinion|April 30, 2025
Healthcare resource use and clinical events associated with neutropenia among adult kidney transplant recipients receiving valganciclovir or ganciclovir prophylaxis: a matched case-control cohort studyWeijia Wang, Pamela A Moise, Michael Wong, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2007
Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemiaPamela A Moise, Davida S Smyth, Nadia El-Fawal, et al.
World Journal of Transplantation|June 19, 2025
Clinical events and healthcare resource utilization associated with neutropenia and leukopenia among adult kidney transplant recipients receiving valganciclovirAndrew P Beyer, Pamela A Moise, Michael Wong, et al.
Antimicrobial Agents and Chemotherapy|July 9, 2008
Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremiaCarlo McCalla, Davida S Smyth, D Ashley Robinson, et al.
Clinical Therapeutics|May 19, 2015
Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus BacteremiaPamela A Moise, George Sakoulas, James A McKinnell, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Microbiology|June 9, 2004
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaGeorge Sakoulas, Pamela A Moise-Broder, Jerome Schentag, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2009
Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studiesPamela A Moise, Davida S Smyth, D Ashley Robinson, et al.
The Journal of Infectious Diseases|December 17, 2009
Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypesPamela A Moise, Alan Forrest, Arnold S Bayer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapyPamela A Moise-Broder, George Sakoulas, George M Eliopoulos, et al.
Mycoses|February 6, 2023
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospitalsKarri A Bauer, Kalvin Yu, Pamela A Moise, et al.
Current Medical Research and Opinion|April 30, 2025
Healthcare resource use and clinical events associated with neutropenia among adult kidney transplant recipients receiving valganciclovir or ganciclovir prophylaxis: a matched case-control cohort studyWeijia Wang, Pamela A Moise, Michael Wong, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2007
Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemiaPamela A Moise, Davida S Smyth, Nadia El-Fawal, et al.
World Journal of Transplantation|June 19, 2025
Clinical events and healthcare resource utilization associated with neutropenia and leukopenia among adult kidney transplant recipients receiving valganciclovirAndrew P Beyer, Pamela A Moise, Michael Wong, et al.
Antimicrobial Agents and Chemotherapy|July 9, 2008
Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremiaCarlo McCalla, Davida S Smyth, D Ashley Robinson, et al.
Clinical Therapeutics|May 19, 2015
Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus BacteremiaPamela A Moise, George Sakoulas, James A McKinnell, et al.
Pageof 3